Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

At the J.P. Morgan Healthcare Conference, the Biotech Sisterhood assembled in Union Square to showcase the large group of ...

BioSpace Senior Editor Annalee Armstrong headed to the J.P. Morgan Healthcare Conference with a months-long story idea ...

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a ...

Several members of our firm’s life sciences team were on the ground at the 43rd Annual J.P. Morgan Healthcare Conference in ...

The deal could help funnel eligible patients towards Teladoc’s other offerings, including chronic condition management ...

Shares of Teladoc Health (NYSE: TDOC) climbed 5.8% Wednesday after the company announced its definitive agreement to acquire Catapult Health, a provider of virtual preventive care services. The $65 ...

Meeting Tuesday morning at the J.P. Morgan Healthcare Conference this year, women leaders in life sciences, women’s health, and entrepreneurship ...

During a panel discussion at this year’s Fierce JPM Week—which took place alongside the annual J.P. | This week on “The Top ...

Moments after Regeneron CEO Len Schleifer scolded analysts for asking too many questions about the disappointing sales of eye ...

Teladoc Health has signed a definitive agreement to acquire virtual preventive care company Catapult Health to bolster the ...

Q2 2025 Earnings Call Transcript February 4, 2025 Premier, Inc. misses on earnings expectations. Reported EPS is $0.25 EPS, ...